Anti-inflammatory and healing effects of pulsed ultrasound therapy on fibroblasts.
The aim of this study was to analyze the effects of low intensity pulsed ultrasound therapy under different pulse regimes on cultures of semi-confluent L929 fibroblasts, evaluating cell viability, anatomical structural alterations, modulation of VEGF (Vascular endothelial growth factor), IL-6 (Interleukin - 6), Col1α1, Col1α2 (Type 1 alpha 1 and alpha 2 collagens) and FgF7 (Fibroblast growth factor 7), and the amount of inflammatory mediators IL-2, IL-4, IL-6, IFN-γ, TNF, IL-17A and IL-10 at 24, 48 and 72 hours. The design was experimental study. The treatments consisted of 0.2 W/cm doses at a frequency of 1 MHz, pulsed as 10 and 20%. Viability was assessed by the MTT assay [3-(4,5-dimethylthiazole)-2,5-diphenyltetrazolium bromide], gene expression by RT-qPCR and cytokine quantification by flow cytometry. At 48 hours, ultrasound enhanced cell viability, and affected IL-6 cytokine production and VEGF, IL-6, Col1α1, Col1α2 and FgF7 gene modulation. Low-intensity pulsed ultrasound therapy had a biostimulatory effect on semi-confluent in vitro L929 fibroblast cells, where the group with a dose of 0.2 W/cm-10% (G2) presented higher responses, in all the analyzed aspects, towards the dose pulsed to 20%, confirming its therapeutic properties related to the initial phases of tissue healing.